International Registry for TRPM3-associated Disorders

NCT07690111 · tracked via the Priya Life Science Germany tracker

Sponsor

Charite University, Berlin, Germany

Phase

Observational

Started

2026-01-01

Last updated

2026-07-08

Condition(s) studied

TRPM3

Study summary

The goal of the TRPM3Care-registry is to record the disease progression of patients with TRPM3-associated disorders. This allows us to compare the disease progression and the success of different therapies, as well as to examine their impact on quality of life.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Variant in the TRPM3 gene Exclusion Criteria: * no consent from patient/familiy

Primary outcome measure(s)

Developmental Delay — 10 years
Development in patients

Trial sites (1)

Facility	City	Region	Status
Charité- Universitätsmedizin Berlin- Neuropediatrics	Berlin	State of Berlin	Recruiting

More Charite University, Berlin, Germany trials in Germany

Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke)(Stroke-CORE) Starting soon

Berlin-Brandenburg Pregnancy Cohort Recruiting

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture Recruiting

Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2) Recruiting

Establishment of 2D and 3D Primary Cell Cultures From Gastric and Gastroesophageal Junction Cancer Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07690111 on ClinicalTrials.gov ↗ ← All trials in Germany